New Vaccine Close To Distribution

The U.S. Food and Drug Administration said the one-dose Johnson & Johnson COVID-19 vaccine had met the requirements for emergency use authorization, another step toward the approval of a third shot for the United States. Analysts say no specific safety concerns were found in subgroup analyses by age, race, ethnicity, medical comorbidities, or prior COVID infection.